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Abstract: The closely related human and murine proteins Hap46/BAG-1M and BAG-1, 
respectively, were discovered more than a decade ago by molecular cloning techniques. 
These and the larger isoform Hap50/BAG-1L, as well as shorter isoforms, have the 
ability to interact with a seemingly unlimited array of proteins of completely unrelated 
structures. This problem was partially resolved when it was realized that molecular 
chaperones of the hsp70 heat shock protein family are major primary association 
partners, binding being mediated by the carboxy terminal BAG-domain and the ATP-
binding domain of hsp70 chaperones. The latter, in turn, can associate with an almost 
unlimited variety of proteins through their substrate-binding domains, so that ternary 
complexes may result. The protein folding activity of hsp70 chaperones is affected by 
interactions with Hap46/BAG-1M or isoforms. However, there also exist several proteins 
which bind to Hap46/BAG-1M and isoforms independent of hsp70 mediation. Moreover, 
Hap46/BAG-1M and Hap50/BAG-1L, but not the shorter isoforms, can bind to DNA in a 
sequence-independent manner by making use of positively charged regions close to their 
amino terminal ends. This is the molecular basis for their effects on transcription which 
are of major physiological relevance, as discussed here in terms of a model. The related 
proteins Hap50/BAG-1L and Hap46/BAG-1M may thus serve as molecular links 
between such diverse bioactivities as regulation of gene expression and protein quality 
control. These activities are coordinated and synergize in helping cells to cope with 
conditions of external stress. Moreover, they recently became markers for the 
aggressiveness of several cancer types. 
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1. The protein family   
 
Two related proteins, BAG-1 and Hap46, were discovered independently in the mid 1990s using 
molecular genetic methods by three research groups who were interested in quite different biological 
phenomena. We knew from previous experiments using chemical crosslinking methods with the 
liganded and activated glucocorticoid receptor, a member of the nuclear receptor superfamily, that this 
protein is able to form large complexes with other proteins while associating with the genome. 
Therefore, we set out to search for interaction partners by using immunochemical screening of a 
human liver cDNA library, since liver is a major target for this class of hormones. We thus cloned a 
cDNA of 1,322 base pairs which encodes a 274 residue polypeptide [1,2]. The apparent molecular 
weight is about 46 kDa in SDS polyacrylamide gels, thus the original designation RAP46 for 
“receptor-associating protein of 46 kDa apparent molecular mass” [2]. However, this name was 
subsequently changed to Hap46, i.e. “hsp70/hsc70-associating protein“ [3] when we realized that 
hsp70 heat shock proteins are the most prominent interaction partners (see below). In a similar 
approach, Takayama et al. [4] looked for binding partners for the anti-apoptotic protein Bcl-2 in a 
mouse embryonic expression library and obtained a cDNA clone of 830 base pairs coding for a 219 
amino acid sequence. As this sequence produced in transfection experiments inhibitory effects on 
apoptosis induced by several treatments, the protein was termed “Bcl-2-associated athanogen“, in 
short  BAG-1 [4], with the Greek word athánatos meaning “anti-death“. A similar murine cDNA 
expression library was also used by a third research group [5] who employed the cytoplasmic domain 
of the plasma membrane receptor for hepatocyte growth factor as interacting component in their 
cloning approach. They isolated several independent clones of different length, which however 
contained the same cDNA coding for the BAG-1 protein of about 29 kDa apparent molecular size. 
These authors further described complex formation not only with the hepatocyte growth factor 
receptor, but also with that for platelet-derived growth factor. Again, anti-apoptotic effects were 
observed [5].   
At first, it was quite surprising that the above described proteins, human Hap46 and murine BAG-1, 
are up to 25 % different in size and have distinct amino terminal regions, although they are 
homologous otherwise. It then turned out that they are but two members of a protein family which 
comprises several isoforms. 
While human Hap46 of 274 amino acid residues is synthesized from an AUG codon and thus starts 
out with methionine (cf. Figure 1), it became evident upon cloning of 5’-extended cDNAs that a larger 
isoform exists. This originates from an upstream CUG non-canonical start codon, begins with leucine 
and contains 345 amino acids [6]. In comparison to Hap46, it is 71 amino acids longer at the amino 
terminal end, and since the apparent molecular weight is roughly 50 kDa, it has been called p50, Int. J. Mol. Sci. 2009, 10                 
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Hap50 or BAG-1L (L for long). This isoform is present in human and murine cells [6-8]. For the sake 
of nomenclature, human Hap46 was then renamed BAG-1M (M for medium). There also exist shorter 
human isoforms (cf. Figure 1), most importantly the 230 residue Hap33/BAG-1S (S for small), as well 
as the even shorter form Hap29/BAG-1S of 207 amino acids [7,8], which originate from AUG codons 
further downstream. Expression of these isoforms occurs at very different levels in different cell types, 
however, Hap33/BAG-1S appears to be the most prominent form in the majority of cells under normal 
conditions and Hap29/BAG-1S is not consistently detected in all cells. 
There is no direct correlate to human Hap46/BAG-1M in the mouse since the murine message has a 
GUG (coding for valine) in the corresponding position instead of AUG. The originally discovered 219 
residue murine protein [4] is a somewhat shorter isoform which is produced from an internal AUG 
start codon [9] and roughly corresponds to human Hap33/BAG-1S. In order to avoid confusions, this 
protein is called “mouse BAG-1S” in this review. Most significantly, however, the murine and human 
protein factors are highly homologous. 
The message is roughly 1.4 kb long [2] and harbors several translation initiation codons, giving rise 
to the series of polypeptide chains depicted schematically in Figure 1. The gene coding for these 
proteins is called “Bag1“ and is located on human chromosome 9 in region p12 [10]; it is roughly 10 
kb in size and contains seven exons. The promoter covers positions -353 to -54 upstream of the first 
translational start codon, lacks a TATA box but has a CCAAT box and contains binding sites for 
several transcription factors, which may be important in regulating the expression [11]. Interestingly, 
p53 mutants obtained from human tumors are able to upregulate the Bag1 promoter [11]. Moreover, 
expression of the Bag1gene is modulated by methylation reactions [12]. 
 
Figure 1. Domain structure of polypeptides. Blue: potential nuclear localization signals; 
red: basic DNA-binding domain. The sequence in Hap46/BAG-1M is (1)Met-Lys-Lys-
Lys-Thr-Arg-Arg-Arg-Ser-Thr(10). Due to overlap with a potential nuclear localization 
signal, this appears purple in Hap50/BAG-1L; green: acidic hexarepeat domain, consensus 
sequence: Thr-Arg-Ser-Glu-Glu-X; pink: ubiquitin-like domain; orange: hsp70/hsc70 
binding domain or BAG-domain (shown here as originally defined [30,38]).   
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2.  Polypeptide domains 
 
Figure 1 shows that all protein isoforms have a common carboxy terminal region, but differ 
significantly in their amino terminal portions. Consequently, they share the functions mediated by the 
carboxy terminal part, possibly with individual additional molecular properties otherwise. It thus 
appears that all isoforms are roughly equivalent in biochemical reactions mediated by the carboxy 
terminal domain (orange in Figure 1), i.e. interactions with hsp70 heat shock proteins (see below).  
A striking characteristic of Hap50/BAG-1L is a series of positively charged residues in proximity to 
the amino terminus, as is typical for nuclear localization signals (blue in Figure 1). However, 
Hap46/BAG-1M also contains a cluster of basic amino acids right next to its amino terminus. Both of 
these regions in Hap46/BAG-1M and Hap50/BAG-1L are of significance for interactions with nucleic 
acids (see below). By contrast, isoforms Hap33/BAG-1S, Hap29/BAG-1S, and mouse BAG-1S do not 
contain these basic sequences and — as a consequence — are unable to bind to DNA. The potential 
nuclear localization signal roughly in the middle of the Hap46/BAG-1M sequence (blue in Figure 1) 
appears to be masked by some as yet unknown mechanism, but apparently becomes activated upon 
heat shock, since a significant portion of Hap46/BAG-1M accumulates in the nuclear compartment in 
response to thermal stress (Figure 2, B vs. A).  
The functional significance of the acidic hexarepeat domain (green in Figure 1) remains rather 
enigmatic at present, as it is quite variable amongst different isoforms. Deletion of this region did 
neither destroy transcriptional stimulation by Hap46/BAG-1M [15] nor was the acidic hexarepeat 
domain required for the inhibition of glucocorticoid-dependent transcription in transfected cells [16]. 
On the other hand, this domain has been reported responsible for the downregulation of glucocorticoid 
receptor mediated transactivation by Hap46/BAG-1M [17].   
 
Figure 2. Intracellular distribution of Hap46/BAG-1M and Hap50/BAG-1L. (A and B) 
HeLa cells were transfected with a construct in which the sequence encoding Hap46/BAG-
1M was coupled to that for the green fluorescent protein GFP. In A, cells were maintained 
at 37°C, in B they were exposed to a 42°C treatment for 2 h. Analysis was by fluorescence 
microscopy. From ref. [13]. (C) HeLa cells, similarly transfected with a construct coding 
for Hap50/BAG-1L coupled to GFP, were maintained at 37°C. In contrast to A and B, the 
cell body and the contours are practically invisible due to the very strong fluorescence 
originating from the nucleus. From ref. [14]. Int. J. Mol. Sci. 2009, 10                 
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The ubiquitin-like domain (pink in Figure 1) is much shorter than ubiquitin itself, but nevertheless 
mediates cooperation with the proteasome machinery of protein degradation [18,19]. Conjugation with 
ubiquitin normally primes proteins for degradation by proteasomes, but Hap46/BAG-1M is relatively 
long-lived, even though it is ubiquitinylated [20]. The ubiquitin-like domain was found to be required 
for promoting the apoptotic activity of a synthetic retinoid [21], and prevention of stress-induced 
growth inhibition by Hap46/BAG-1M and isoforms depended on a conserved lysine residue within 
this domain [22]. On the other hand, the ubiquitin-like domain was expendable for Hap50/BAG-1L to 
affect the regulatory activity of androgen receptors [23]. 
 
3.  Hsp70 molecular chaperones as primary interaction partners 
 
Already the discovery of this new protein family disclosed the unusual property that its members 
interact with several completely unrelated protein structures. Aside from the proteins used in the 
original interaction screening assays (see above), several additional proteins soon became known to be 
able to associate with Hap46/BAG-1M and mouse BAG-1S. These were other members of the nuclear 
receptor family [2,24,25], platelet-derived growth factor receptor [5], Raf-1 protein kinase [26], 
several unrelated transcription factors [3], Siah-1A, a human homologue of Drosophila seven in 
absentia [27], and proteasomes [18]. However, light came into this puzzling problem when it was 
realized that primary and major interaction partners are members of the 70 kDa heat shock protein 
family. When several protein-protein interaction assays were employed to identify direct binding 
partners for Hap46/BAG-1M and mouse BAG-1S, the only polypeptide of significance was about 70 
kDa in size and this was obtained with extracts from very different cells. It was then identified as the 
mammalian heat shock protein hsp70/hsc70 [3, 28-30]. However, to our great surprise the mammalian 
endoplasmic form BiP, as well as the hsp70 homologues in Saccharomyces cerevisiae and of bacterial 
and plant origin were found unable to bind to Hap46/BAG-1M. By contrast, hsp70 contained in Sf9 
cells from the insect Spodoptera frugiperda, used in the baculovirus expression system for producing 
bait proteins, did interact perfectly well [3]. 
The stress-regulated form — hsp70 in the strict sense — originates in eukaryotes from several 
genes whose expression is controlled by heat and other types of stress. However, there also exists a 
slightly larger, but constitutively expressed counterpart, called hsc70. This very fact certainly points to 
some basic cellular function: the “chaperoning“ of misfolded or partially unfolded polypeptides. 
Hsp70s are a large and highly conserved family of molecular chaperones which function in quite 
diverse cellular processes. In particular, they are able to bind a wealth of protein structures, especially 
if these are partially denatured, i.e. if they contain stretches of unfolded or misfolded polypeptides. 
Besides supporting newly synthesized and misfolded polypeptides to find their correct and biologically 
active conformations, they also minimize the aggregation of such proteins and they function in 
translocating proteins through membranes (for reviews, see refs. [31-34]). Moreover, they are 
important for the assembly of multimeric proteins, as for example in generating the heteromeric forms 
of steroid hormone receptors [35,36] and of transcriptional complexes, as pointed out below, as well as 
of several other large protein complexes.  Int. J. Mol. Sci. 2009, 10                 
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All members of the hsp70 heat shock protein family consist of two major domains which are very 
different in structure (for reviews, see refs. [31,34,37]). The amino terminal portion of about 45 kDa is 
build up of two somewhat similar subdomains, I and II, each consisting of several α-helices. Together 
they form the so-called ATP-binding domain with the binding site for nucleotides located in the central 
cleft between them. The carboxy terminal portion of the hsp70 polypeptide is called the substrate-
binding domain. It is intricately folded to accept the various partner proteins for binding in a channel 
within a ß-sandwich structure. Obviously, there is strong functional coupling by conformational 
changes between the ATP-binding and the substrate-binding domains. 
The interaction of Hap46/BAG-1M and all isoforms makes use of the common carboxy terminal 
region, as has originally been shown by deletion of 47 residues from this end of the polypeptide 
[30,38]. Since this interaction is a very prominent property of the protein family, this common portion 
has been called “BAG- domain“ (orange in Figure 1). However, this does not exclude the possibility 
that other regions of Hap46/BAG-1M and isoforms may also contribute to the interaction with hsp70 
molecular chaperones. On the part of hsp70/hsc70, the ATP-binding domain is involved in the 
interaction, while the substrate binding domain remains available for further binding reactions [for 
reviews, cf. refs. 33,34]. This raises the possibility of multiple associations, and experiments with 
model proteins have in fact shown that trimeric complexes are easily formed [3,15,28,30,39]. 
Hsp70/hsc70 molecular chaperones as mediators of interactions also explain why very different bait 
proteins used in the original cloning experiments lead to the discovery of the same molecular 
sequence: hsc70 contained in these systems was able to serve as mediator. Interestingly, variations of 
the BAG-domain also exist in other proteins, which similarly mediate interactions with hsp70 
chaperones; together they constitute the family of eukaryotic BAG proteins [38,40-42]. 
An interesting feature of hsp70 molecular chaperones is the structural flexibility of the two 
subdomains within the ATP-binding domain relative to each other. This was observed in experiments 
which studied the complex of the ATP-binding domain of the prokaryotic hsp70 protein DnaK with its 
regulator GrpE. X-ray crystallography disclosed contacts on both subdomains I and II with a 
significant opening of the cleft between them, as has been described clearly [37]. This readily explains 
why GrpE causes enhancement of the ADP/ATP exchange reaction of DnaK. Even though this 
movement of subdomains came to light by studies with the bacterial hsp70 protein DnaK, it is assumed 
to similarly occur in eukaryotic hsp70/hsc70 forms. Although structurally completely different, 
Hap46/BAG-1M and isoforms are functionally in a way eukaryotic counterparts of GrpE, however 
GrpE plays an essential role for the activity of DnaK in contrast to Hap46/BAG-1M and isoforms, 
whose effects on nucleotide exchange are more moderate. While GrpE binds asymmetrically as a 
dimer to DnaK, Hap46/BAG-1M or isoforms produce stoichiometric 1:1 complexes with eukaryotic 
hsp70 chaperones, even though hsp70s are normally much more abundant within cells. When the 
interaction between the BAG-domain and hsp70 was studied by X-ray analysis, NMR spectroscopy, 
and mutagenesis it was found that it forms a bundle of three α-helices that contact subdomain II of the 
ATP-binding domain [43,44]. Electrostatic interactions are of major importance in this interaction, 
whereby Arg308 (in the human Hap50/BAG-1L sequence) plays a major role, since exchange for 
alanine greatly reduced binding as well as in vitro activity; however other residues are also of Int. J. Mol. Sci. 2009, 10                 
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importance. On the part of hsp70, the major portion of subdomain II suffices for binding, although the 
affinity is greatly reduced relative to the intact ATP-binding domain [45]. The techniques of phage 
display and of peptide scanning, however, resulted in several potential contact sites in two major 
regions, one on each subdomain I and II [46], suggesting that Hap46/BAG-1M and isoforms may use 
more than one contact with hsp70 chaperones for exerting their cellular effects. Binding of the BAG-
domain probably favors an alternative structure of the ATP-binding domain that has a more open 
conformation [47], again reflecting flexibility of the structure.  
With hsp70 molecular chaperones as major helpers in protein folding reactions in conjunction with 
hsp40, there immediately arose the question whether Hap46/BAG-1M and isoforms may affect this 
fundamental cellular activity in addition to the nucleotide exchange reaction. This was indeed 
observed in in vitro assays which employed various denatured proteins, in particular firefly luciferase 
and ß-galactosidase. While most reports describe inhibition of protein reactivation concomitant with 
reduced binding of misfolded proteins to the hsp70 molecular chaperone, positive effects on protein 
folding have also been observed [48-50]. This discrepancy is probably caused by details in 
experimental systems. Particularly in the presence of inorganic phosphate and at low concentrations of 
Hap46/BAG-1M protein renaturation was activated [50]; also the relative molar concentrations of 
hsp70 chaperone and Hap46/BAG-1M or isoform, as well as the type of isoform play important roles. 
Importantly, experiments with intact mammalian cells in culture also showed attenuation by 
overexpression of mouse BAG-1S of refolding denatured luciferase introduced into cells and thermally 
inactivated within them [51]. Thus Hap46/BAG-1M and isoforms have quite adequately been called 
cochaperones. This family of proteins, however, is but one of several known cochaperones which 
affect the protein folding and nucleotide exchange reactions of hsp70s, albeit in quite different ways. 
They certainly influence each others effects [see for example, refs. 28,52], so that a functional network 
exists that regulates the activities of hsp70 molecular chaperones.  
 
4.  Interactions with proteins independent of hsp70 molecular chaperones 
 
In principle, Hap46/BAG-1M and isoforms might interact with various protein structures through 
mediation by hsp70/hsc70 molecular chaperones, as pointed out, or they may do so directly, i.e. 
independent of such mediation. In addition, Hap46/BAG-1M and Hap50/BAG-1L have the ability to 
bind to DNA, as discussed below. Of course, combinations between these types of interactions are 
expected to exist (see below). In any event, a multitude of bioactivities is produced by Hap46/BAG-
1M and isoforms by such interactions. 
To check for the involvement of hsp70/hsc70 molecular chaperones, we compared the retention of 
in vitro synthesized and radiolabeled proteins on a matrix to which either full-length Hap46/BAG-1M 
or deletion variant Hap46/BAG-1MΔC47 had been coupled from which the carboxy terminal 47 amino 
acid residues, the BAG-domain, are missing [15]. As expected, hsc70 contained in large amounts in 
the reticulocyte lysate used for in vitro translation was not retained by the matrix containing the 
deletion variant (Figure 3 A). Moreover, this variant matrix did not bind any protein that requires 
mediation by hsc70 molecular chaperones, as is the case for several transcription factors which had Int. J. Mol. Sci. 2009, 10                 
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been selected to be structurally different (Figures 3 B to F). Examples are members of the nuclear 
receptor superfamily, like the glucocorticoid receptor (GR) and the estrogen receptor (ER), as well as 
the cAMP response element binding protein CREB, the regulator of osteoblast differentiation 
CbfA1/Runx2, and c-Fos, a component of transcription factor AP-1. By contrast, c-Jun, the companion 
protein of c-Fos in AP-1, and Gax, a transcription factor involved in regulating cell viability, attached 
to roughly similar extents to both matrices (Figures 3 G and H). Apparently, these protein factors do 
not depend on any hsp70 molecular chaperone as binding mediator; c-Jun even appeared to interact 
somewhat better with the matrix devoid of hsc70 binding ability. 
Protein kinase Raf-1 was the first example of a protein with the ability for direct and specific 
interaction with mouse BAG-1S, thereby causing activation of the kinase activity [26]. The binding 
site was mapped adjacent to and partially overlapping with that for hsp70 and point mutations within 
the BAG-domain which destroyed hsp70 binding activity were still able to activate the Raf-1 kinase 
[54]. Induction of hsp70 by cell stress caused downregulation of the kinase activity in mammalian 
cells. Thus competition of Raf-1 and hsp70 for binding to BAG-1S was proposed as molecular basis 
for the coordination of signals for cell growth and mitogenesis [54]. 
The retinoblastoma susceptibility protein Rb is another direct binding partner of Hap46/BAG-1M 
since it is able to interact with mutants defective in hsp70/hsc70 binding [55]. The complex of Rb and 
Hap46/BAG-1M is stable enough so that Hap46/BAG-1M is cotransported by Rb into the nucleus. 
The complex is disrupted by the human papilloma virus oncoprotein E7, an inhibitor of Rb protein 
interactions [55], thus emphasizing the specificity of complex formation. This modulation of 
subcellular localization of Hap46/BAG-1M has significant consequences for the survival of colorectal 
epithelial and tumor cells [56], suggesting a function of Rb as physiological regulator of  
Hap46/BAG-1M. 
Hap50/BAG-1L was observed to stimulate the transactivation function of the androgen receptor, 
another member of the nuclear receptor superfamily, however, Hap46/BAG-1M did so only when 
forced into the nucleus [23]. While the carboxy terminal hsp70 binding BAG-domain mediates in vitro 
interaction, the amino terminal portion of Hap50/BAG-1L is required for nuclear localization and for 
eliciting the biological effect [23]. This is quite reasonable since both the ligand-activated androgen 
receptor as well as Hap50/BAG-1L or Hap46/BAG-1M need to be nuclearly localized in order to 
cooperate functionally. A similar argument may also apply to the interaction with both types of 
estrogen receptors, since Hap50/BAG-1L, but not the shorter isoforms, increased estrogen-dependent 
transcription in mammary carcinoma cells [57]. The cooperation with members of the nuclear receptor 
family, however, is not at all uniform, but rather complex [58]. Transactivation by the vitamin D 
receptor was also enhanced by Hap50/BAG-1L, but not by shorter non-nuclear forms, and binding 
again depended on the amino terminal part of the molecule. Interestingly, not only a variant from 
which the carboxy terminal BAG-domain had been deleted, but also overexpression of Hap50/BAG-
1L itself inhibited vitamin D-dependent transactivation [59,60], suggesting a regulatory role of 
Hap50/BAG-1L in the action of vitamin D.  
 Int. J. Mol. Sci. 2009, 10                 
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Figure 3. Formation of Hap46/BAG-1M complexes with several transcription factors. 
Transcription factors, as indicated, were synthesized as radiolabeled proteins by in vitro 
transcription/translation from recombinant constructs. They were then incubated in the 
presence of hsc70, contained in the reticulocyte lysate, with Sepharose matrices to which 
either Hap46/BAG-1M (lanes 1) or deletion variant Hap46/BAG-1MΔC47 (lanes 2) had 
been attached. After extensive washing, retained proteins were eluted and analyzed by 
electrophoresis in SDS-containing polyacrylamide gels and radioautography. 
Glucocorticoid receptor (GR); Estrogen receptor (ER). From ref. [53]. 
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Interestingly, a variant of Hap50/BAG-1L has been isolated from a human T-cell cDNA library in a 
yeast two-hybrid screen. This turned out to be carboxy terminally truncated by 34 amino acids and 
harbors alterations within terminal residues [61]; as a consequence, it is unable to interact with hsp70 
molecular chaperones. This variant is nevertheless able to associate with the tubulin-associating 
protein RP1. Thus RP1 is another direct interaction partner of Hap50/BAG-1L and most probably of 
other isoforms as well, thus linking these to the microtubule system. The functional consequences of 
this interaction for cellular mobility, cytokinesis and the cytoskeleton are certainly of interest.  
 
5.  Interaction with DNA 
 
Although Hap46/BAG-1M is an acidic protein with a pI of 5.3, it nevertheless contains a prominent 
cluster of basic amino acids right next to the amino terminus [2,10] which is quite unique. This region 
was in fact found to be involved in binding to DNA (Figure 4 A, lane 4 vs. 2). The DNA may be linear 
(Figure 4 A) or circular (Figure 4 B), and neither the origin nor the size of the DNA matter, except that 
a minimum length is required [13,15]. Multiple copies of Hap46/BAG-1M can simultaneously 
associate with DNA, possibly in a cooperative manner, since the upshift of complexes upon gel 
electrophoresis occurs progressively [13,15]. 
 
Figure 4. Binding of Hap46/BAG-1M to DNA. (A) A radiolabeled 283 basepair DNA 
fragment was either employed as such (lane 1) or used for electrophoretic mobility-shift 
assays with full-length Hap46/BAG-1M (lane 2), a deletion variant missing the amino 
terminal 10 residues (lane 4), or Hap46/BAG-1M plus hsc70 (lane 3) . Detection was by 
autoradiography. From ref. [13]. (B) A circular plasmid of about 6 kilobases (as monomer 
and in dimeric form) was submitted to electrophoresis in 0.8% agarose gels either as such 
(lane 1), after incubation with Hap46/BAG-1M (lane 2) or with Hap46/BAG-1M plus 
hsc70 (lane 3). Detection of DNA was by staining with ethidium bromide. From ref. [15]. 
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In contrast to a previous report which suggested a specific binding site within the Cytomegalovirus 
promoter [62], we did not detect any such nucleotide sequence specificity when we investigated 
Hap46/BAG-1M with two series of overlapping oligonucleotides of about 130 and 240 base pairs 
which cover the entire early gene promoter of the Cytomegalovirus [15]. However, this does not 
exclude limited preferences for some as yet unidentified combinations of nucleotides. On the other 
hand, such non-specific DNA binding completely depends on the positively charged sequence close to 
the amino terminus of the polypeptide chain, which consists of three consecutive lysines and of three 
arginines, separated by a centrally located neutral residue (cf. legend to Figure 1). Mutation analysis 
established that both of these trimeric clusters are required for the DNA binding ability of 
Hap46/BAG-1M [13,16,62], but the exact spacing between them does not matter. This non-specific 
DNA binding motif is involved in down-regulation of glucocorticoid receptor-mediated transactivation 
by Hap46/BAG-1M [16,63], even though the mechanism of this effect is not clear. In Hap50/BAG-1L 
the same basic peptide region (red in Figure 1) is available for interaction with DNA, but the 
polypeptide chain is extended further amino terminally and contains additional basic residues, which 
may be involved as well. 
It is important to point out that both major interaction regions located close to the ends of the amino 
acid sequences of Hap46/BAG-1M and Hap50/BAG-1L, i.e. for DNA binding and for interaction with 
hsp70 molecular chaperones, are available for respective binding reactions at the same time. Thus 
trimeric complexes of the type DNA•Hap46/BAG-1M•hsc70 can easily be formed [13,15], as shown 
in Figure 4 (A and B, lanes 3). In these complexes the substrate-binding domain of hsc70 is still 
available for additional interactions with other proteins, for example transcription factors. 
 
6.  Effect of Hap46/BAG-1M and Hap50/BAG-1L on transcription 
 
When we realized that Hap46/BAG-1M has the ability to interact with DNA, there immediately 
arose the idea that it might affect transcriptional activities, in particular since thermal stress causes a 
significant portion of Hap46/BAG-1M to translocate from the cytoplasm to the cell nucleus (cf. Figure 
2, B vs. A). By contrast, Hap50/BAG-1L (Figure 2 C) is mainly localized in the nucleus under normal 
cell culture conditions [6,7,14,23], a fact that immediately points to a function within the nucleus. 
Figure 5 A shows in vitro transcription experiments using HeLa nuclear extracts. Addition of 
Hap46/BAG-1M to these assays resulted in roughly a 10-fold stimulation of transcription from various 
templates [13,15]. It did not matter whether eukaryotic or prokaryotic DNA was used as template and 
whether or not it contained promoter elements. The fact that the transcripts have no distinct length 
suggests random initiation of transcription and termination at the end of linearized DNA fragments. 
Involvement of the amino terminal DNA binding region in the effect on transcription became evident 
from the observation that deletion of the 10 amino terminal residues from Hap46/BAG-1M resulted in 
complete loss of stimulation [13]. 
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Figure 5. Stimulation of transcription by Hap46/BAG-1M and Hap50/BAG-1L. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) In vitro transcription assays were carried out with HeLa nuclear extracts using either plasmid 
DNA (lanes 1 and 2), linearized prokaryotic DNA without a promoter (lanes 3 to 5), or eukaryotic, 
linear DNA without a promoter (lanes 6 to 8). Hap46/BAG-1M (lanes 2, 4, 7) or the carboxy 
terminally deletion variant Hap46/BAG-1M　C47 (lanes 5 and 8) were added, as indicated. Newly 
synthesized radiolabeled RNA was analyzed by gel electrophoresis and autoradiography. Positions 
of RNA markers are shown along the margins. From ref. [15]. (B) DU145 cells were transfected 
with an expression vector coding for Hap46/BAG-1M (lanes 3 and 4) or not (lanes 1 and 2). As 
indicated, cells were then submitted to heat treatment at 42°C for 2 h. Newly synthesized 
radiolabeled poly(A)
+RNA was analyzed by gel electrophoresis and autoradiography (upper panel). 
The positions of 18 S and 28 S rRNAs are shown along the margin. The same filters were 
subsequently used for Northern hybridization with radiolabeled cDNAs encoding hsp70 or hsp40 
(lower panels). From ref. [13]. (C) HeLa cells were transfected with an expression vector coding 
for Hap50/BAG-1L (lower panel) or not (upper panel) and used for nuclear runoff transcription 
assays. Newly synthesized radiolabeled RNAs were probed with dot-blotted cDNAs encoding the 
glucocorticoid receptor (GR), the estrogen receptor (ER), c-Jun, or c-Fos, as indicated. Detection 
was by autoradiography. From ref.[14]. Int. J. Mol. Sci. 2009, 10                 
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These in vitro experiments were then complemented by studies with intact human cells transfected 
with an expression vector for Hap46/BAG-1M. Upon heat treatment of these cells which results in 
nuclear translocation (cf. Figure 2 B), overexpression of Hap46/BAG-1M largely compensated the 
drastic shut-down of cellular transcription which normally occurs following heat stress (Figure 5 B 
upper panel, lane 4 vs. 2). Interestingly, induction of heat shock proteins hsp70 and hsp40 was further 
stimulated by Hap46/BAG-1M (Figure 5 B lower panels, lane 4 vs. 2). Upon overexpressing 
Hap50/BAG-1L in a similar cell system, we again observed increased transcriptional activities (cf. 
Figure 5 C). The expression of several endogenous genes which are under cellular regulation, like 
those coding for c-Jun, c-Fos, or the receptors for glucocorticoids or estrogens were stimulated, while 
that for actin, for example, was not enhanced [14]. 
 
7.  Molecular model for the effects on transcription   
 
Taking the above observations into consideration, it appears that the effects of Hap46/BAG-1M and 
Hap50/BAG-1L on transcription are of major physiological relevance. This activity of Hap46/BAG-
1M is discussed here in terms of a molecular model that is depicted in Figure 6. Two prominent 
features of this protein are taken into account: DNA binding ability and the potential to interact with a 
variety of transcription factors either by mediation through hsp70 molecular chaperones or directly (cf. 
Fig 3). Several molecules of Hap46/BAG-1M might bind simultaneously to a stretch of DNA within a 
region of transcriptionally active chromatin and establish contacts to the transcriptional apparatus 
itself, as well as to transcripion factors attached to DNA in cis, but possibly at distant locations. In this 
way, Hap46/BAG-1M may help to assemble various cofactors into functional complexes, eventually 
causing increased expression of the respective gene. A transcription factor attached to Hap46/BAG-
1M, as shown in Figure 6, may for example, be identical to a steroid hormone receptor, which itself is 
bound to a specific response element on the DNA in some distance to the gene to be transcribed.  
The same considerations similarly apply to the large isoform Hap50/BAG-1L. Interestingly, 
Hap50/BAG-1L was found to increase estrogen-dependent transcription in mammary carcinoma cells 
and thus turns out as important determinant of estrogen function [57]. Of course, several transcription 
factors might come into contact through multiple molecules of Hap46/BAG-1M or Hap50/BAG-1L 
attached to DNA. Chromatin immunoprecipitation studies in which Hap50/BAG-1L, the molecular 
chaperone hsp70, and the androgen receptor were found targeted to the relevant response element [65] 
support the above notion and clearly favor the nucleation of transcriptional regulatory complexes, as 
proposed here. 
The effects of Hap46/BAG-1M and Hap50/BAG-1L on transcription, however, do not necessarily 
need to be positive, and in case of steroid hormone receptors as transcriptional regulators, the 
responses are not at all uniform [58]. The inhibitory activity of Hap46/BAG-1M on glucocorticoid 
receptor-mediated transcription was found to depend on the amino terminal DNA binding region, 
while Hap33/BAG-1S in contrast, did not elicit a similar effect. In addition, an intact carboxy terminal 
domain for interaction with hsp70 molecular chaperones was also found to be required [16,63]. This Int. J. Mol. Sci. 2009, 10                 
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implies that both functional domains close to the ends of the Hap46/BAG-1M sequence need to be 
present in cis. 
 
Figure 6. Molecular model for the effects of Hap46/BAG-1M on transcription. The 
transcription initiation complex is shown in a simplified version. Arbitrarily, three 
molecules of Hap46/BAG-1M are depicted in association with DNA and are supposed to 
establish contacts via hsp70 molecular chaperones. Pol II: RNA polymerase II; TFII: basal 
transcription factor II; RE: response element on DNA; REBP: specific response element-
binding protein, for example a liganded and activated steroid hormone receptor. From 
ref.[64]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The molecular model of Figure 6 suggests several details which still require experimental 
elucidation. Most importantly, it will be of interest which genes or groups of genes are affected by 
Hap46/BAG-1M and by Hap50/BAG-1L. In addition, it will be interesting to find out how various 
transcription factors cooperate molecularly with Hap46/BAG-1M and Hap50/BAG-1L to bring about 
specific effects. In addition to the tumor suppressor protein Rb, c-Jun, and Gax, other transcription 
factors may interact directly with the transcription stimulating protein Hap46/BAG-1M, i.e. 
independent of hsp70 molecular chaperones. Transcription factor AP-1 is of particular interest in the 
present context since one component, c-Fos requires mediation by an hsp70 chaperone, while the 
other, c-Jun is able to interact directly with Hap46/BAG-1M (cf. Figures 3 F and G). It will be 
interesting to see which region of Hap46/BAG-1M is involved in this direct interaction and whether it 
overlaps with some of the other binding sites. The above difference between c-Fos and c-Jun is of 
significance as they form functionally active heterodimers in AP-1, and the DNA binding of 
heteromeric AP-1 was found to be selectively modified by hsp70 heat shock proteins relative to 
homodimeric c-Jun [66]. This supports the notion that the DNA binding proteins Hap46/BAG-1M and 
AP-1 together with hsp70 molecular chaperones cooperate in forming a network of protein-protein  Int. J. Mol. Sci. 2009, 10                 
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and protein-DNA interactions which may be involved in targeting and activating the basal 
transcription machinery. 
While addition of Hap46/BAG-1M to the in vitro transcription system clearly caused a rather large 
positive effect (cf. Figure 5 A, lanes 2, 4, and 7 vs. 1, 3, and 6), it came as a surprise that the carboxy 
terminal deletion variant Hap46/BAG-1MΔC47 also produced some, albeit moderate stimulation [15], 
as shown in Figure 5 A (lanes 5 and 8 vs. 3 and 6). This points to involvement of hsp70 molecular 
chaperones and suggests that they as well play an important role in transcription. Remodeling of 
transcriptional regulatory complexes by molecular chaperones has indeed been pointed out before 
[67,68]. It is of significance in this context that newly synthesized hsp70 in response to cellular stress 
readily becomes nuclearly localized [69]. Since Hap46/BAG-1M also accumulates in the cell nucleus 
following heat shock, cooperation between these proteins to affect transcription, as proposed in the 
model of Figure 6, appears reasonable for regulating cellular activities. 
 
8.  Concluding remarks 
 
In contrast to Hap46/BAG-1M and Hap50/BAG-1L, the prominently expressed short isoform 
Hap33/BAG-1S which is inert towards DNA appears most suitable for affecting protein folding and/or 
degradation. Since multiple biochemical reactions possibly cooperate in eliciting complex cellular 
responses, it is conceivable that modulation of transcription by Hap50/BAG-1L or Hap46/BAG-1M as 
well as the effects of Hap33/BAG-1S on refolding or degradation of misfolded proteins contribute to a 
cells defense against apoptosis. It will be important to clarify the individual shares of these cellular 
reactions. Depending on its prevalent intracellular localization, Hap46/BAG-1M may even serve a 
dual purpose: transcriptional modulation within the nucleus and control of protein functionality in the 
cytoplasm, thus providing a molecular link between such diverse activities and helping the cell to 
survive under adverse conditions. The pleiotropic activities of Hap46/BAG-1M and isoforms within 
the nucleus may also include control of protein quality. In any event, the intracellular localization of 
Hap46/BAG-1M and isoforms is rather dynamic, with relocalization possibly depending on specific 
signals as well as on the distribution of interacting protein factors, most importantly hsp70 chaperones. 
Thus, MCF7 human mammary carcinoma cells under heat stress were described to relocalize 
Hap33/BAG-1S from the cytoplasm to the nucleus [21] concomitant with nuclear accumulation of 
hsp70, thereby preventing stress-induced growth inhibition. Recruitment of Hap46/BAG-1M to the 
nucleus by activated glucocorticoid receptors has also been reported [17], but it is not clear whether 
this occurs in conjunction with hsp70 molecular chaperones. As mentioned above, nuclear transport of 
Hap46/BAG-1M may as well occur together with the retinoblastoma protein Rb [55,56]. Nevertheless, 
the regulation of expression of different isoforms needs to be investigated, which may depend, at least 
to some extent, on cap-independent initiation of translation at internal ribosome entry sites [9,70]. This 
is of interest since stage- and site-specific expression of isoforms has been observed during early 
murine development [71]. Moreover, the involvement of these proteins in the regulation of cell 
differentiation has been observed in several systems [72,73].   Int. J. Mol. Sci. 2009, 10                 
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A very exciting case of regulation was discovered upon disrupting the Bag1 gene in mice [74]. 
Homozygous Bag1
-/- embryos were severely growth-retarded, died before term, and showed multiple 
developmental defects. Particularly, cell survival within the nervous and hematopoietic systems was 
affected, again emphasizing the anti-apoptotic potential of BAG-1 proteins. Even though the protein 
kinases Raf/ERK and Akt were per se not defective in these mutant animals, the protein 
phosphorylation pattern was affected with loss of phosphorylation of the regulatory protein Bad at 
Ser136, which may be caused by changes in intracellular distribution and targeting [74]. These 
observations suggest that at least one of the products of the Bag1 gene functions as mediator of 
extracellular survival signals which normally prevent apoptosis in certain stem cells and point to the 
exciting fact that members of the Hap46/BAG-1M and Hap50/BAG-1L protein family fulfill some 
vital function within the mammalian organism. It is of interest to find out to which extent hsp70 
molecular chaperones are involved in the above cellular effects. The growth of neurites has been 
studied in cell culture using rat phaeochromocytoma cells PC12 primed with NGF [75]. It was found 
that overexpression of the small isoform BAG-1S interferes with neurite extension and that interaction 
with an hsp70 molecular chaperone plays a crucial role in this effect. By contrast, the large isoform 
Hap50/BAG-1L did not inhibit neurite outgrowth in such neurotrophin-treated cells. Significant 
differences in intracellular localization of these isoforms may be responsible for such  
functional differences.   
Obviously, Hap46/BAG-1M, Hap50/BAG-1L and isoforms play an important role in modulating 
cell survival. This is of particular importance under cellular stress, in neoplastic cell conditions and 
even under anti-tumor therapy. Cells highly expressing the Bag1 gene are probably selected for by 
cytotoxic treatments. Thus, multidrug-resistant cells of decreased sensitivity towards apoptosis were 
observed to express Hap46/BAG-1M and Hap33/BAG-1S at rather high levels [76]. 
Hap50/BAG-1L and Hap46/BAG-1M may be regarded as pro-survival proteins, and thus became 
markers for the aggressiveness of various cancers, in particular of mammary carcinomas; they are 
predictive factors for the clinical prognosis of patients. Such correlations have been observed in many 
clinical and cell culture studies [for example, refs. 7,77-85]. Hap50/BAG-1L in particular is often 
expressed at rather high levels in tumors and metastases as compared to normal cells. It is of interest in 
this context that expression of the Bag1 gene is enhanced by tumor-derived p53 mutants [11] and that 
methylation reactions play an important role in its expression [12]. Consequently, Hap50/BAG-1L and 
Hap46/BAG-1M may serve in the future as molecular targets for therapeutic approaches, as has been 
discussed [83,86]. Indeed, the immunosuppressant rapamycin [87,88] and the protein kinase inhibitors 
flavopiridol and 7-hydroxy-staurosporine [89] are known to downregulate the expression of the Bag1 
gene, thereby affecting apoptotic cell responses. By contrast, interleukin-2 as well as other cell 
survival signals were found to upregulate the expression of the Bag1 gene in different cell types [9,87]. 
Retinoic acid-induced apoptosis in breast cancer cells in culture is inhibited by the interaction of 
Hap33/BAG-1S with retinoic acid receptors and interference with their ability to bind to specific DNA 
response elements [25], while the apoptotic activity of N-(4-hydroxyphenyl)retinamide, used for 
chemoprevention and treatment of various cancers, was enhanced by overexpression of Hap50/BAG-
1L or shorter isoforms in a cervical carcinoma cell line [21]. On the other hand, HeLa cells in which Int. J. Mol. Sci. 2009, 10                 
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the levels of Hap50/BAG-1L and Hap33/BAG-1S were down-regulated by RNA interference, had 
lower growth rates and became less sensitive to several anti-cancer drugs [90]. Also, overexpression of 
the Bag1 gene in mammary carcinomas may limit the efficacy of PPARγ agonists, like 15-deoxy-PGJ2, 
as apoptosis-inducing agents [91]. This brief discussion already points to the complexity of the 
problem and certainly shows that much more basic information is needed. Nevertheless, some of the 
above mentioned observations raise the hope that it will be possible in the future to manipulate the 
cellular levels of Hap50/BAG-1L and Hap46/BAG-1M. It could thus be highly beneficial for the in 
situ treatment of several cancer types if the levels of these isoforms within tumor cells were lowered 
by specific agents. This may then occur either in conjunction with hsp70 chaperone activities or 
independent of them. 
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